CLINICAL_TRIALS
trial_result
· 2022-11-14
Clinical Trial Update: A Study of JR-141 in Patients With Mucopolysaccharidosis Type II [Phase 1, Phase 2]
Summary
Phase 1/2 trial of JR-141 in Mucopolysaccharidosis II has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: JCR Pharmaceuticals Co., Ltd. | Conditions: Mucopolysaccharidosis II | Phase 1, Phase 2 | Status: COMPLETED